Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers
Completed
Conditions studied: Alzheimer Disease
In brief
This is an observational study that will collect blood from a finger prick (Capitainer SEP10 single channel device) and assess the accuracy of pTau-217 testing in comparison to previously collected venous blood samples from the same individuals.
Key facts
- Study ID
- NCT07187921
- Run by
- Banner Health
- People needed
- 49
- Starts
- 2025-09-29
- Expected to finish
- 2025-11-12
- Last updated by the study team
- 2025-12-09
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Able and willing to provide informed consent for the eDROP-AD study.
- Enrolled in the Draw-10 study at Banner Alzheimer's Institute-Phoenix and provided at least one venous blood sample.
- Able and willing to fully comply with study procedures defined in this protocol.
- Written and spoken fluency in the English language.
Where it is running
- Banner Alzheimer's Institute — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.